Related references
Note: Only part of the references are listed.Saroglitazar, a PPAR-α/γ Agonist, for Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Double-Blind Phase 2 Trial
Manas Kumar Panigrahi et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2022)
The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-S-induced hepatic stellate cell activation and CCl4-induced hepatic fibrosis in mice
Chao He et al.
LIFE SCIENCES (2021)
Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis
Xin Han et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial
Samer Gawrieh et al.
HEPATOLOGY (2021)
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
Xiaolin Wang et al.
GUT (2021)
Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis
Wei Chen et al.
HEPATOLOGY (2020)
TBtools: An Integrative Toolkit Developed for Interactive Analyses of Big Biological Data
Chengjie Chen et al.
MOLECULAR PLANT (2020)
Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway
Xiaoxue Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-kappa B-TNF alpha pathway
Tianpeng Zhang et al.
JOURNAL OF HEPATOLOGY (2019)
miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells
Baoling Ju et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells
Le Wang et al.
EBIOMEDICINE (2019)
RNA sequencing: the teenage years
Rory Stark et al.
NATURE REVIEWS GENETICS (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression
Song Wei et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
Daehwan Kim et al.
NATURE BIOTECHNOLOGY (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking
Wenshan Zhao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease
Abhishek Satishchandran et al.
GASTROENTEROLOGY (2018)
Hedgehog signalling in liver pathophysiology
Mariana Verdelho Machado et al.
JOURNAL OF HEPATOLOGY (2018)
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra et al.
JOURNAL OF HEPATOLOGY (2018)
A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer
Takuma Tsuchida et al.
JOURNAL OF HEPATOLOGY (2018)
MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression
Liping Ma et al.
CELL DEATH & DISEASE (2018)
miRWalk: An online resource for prediction of microRNA binding sites
Carsten Sticht et al.
PLOS ONE (2018)
Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal
Naoki Ikenaga et al.
GUT (2017)
microRNA changes in liver tissue associated with fibrosis progression inpatients with hepatitis C
Kendall R. Van Keuren-Jensen et al.
LIVER INTERNATIONAL (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis
Shashi Bala et al.
JOURNAL OF HEPATOLOGY (2016)
Endogenous microRNA sponges: evidence and controversy
Daniel W. Thomson et al.
NATURE REVIEWS GENETICS (2016)
MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression
Jeongeun Hyun et al.
NATURE COMMUNICATIONS (2016)
The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway
Dong-ke Yu et al.
ACTA PHARMACOLOGICA SINICA (2015)
Novel insights into the function and dynamics of extracellular matrix in liver fibrosis
Morten A. Karsdal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis
Jonel Trebicka et al.
JOURNAL OF HEPATOLOGY (2013)
Clinical evidence for the regression of liver fibrosis
Elizabeth L. Ellis et al.
JOURNAL OF HEPATOLOGY (2012)
Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection
Verena Bihrer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Regulation of mRNA Translation and Stability by microRNAs
Marc Robert Fabian et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
Integrated Profiling of MicroRNAs and mRNAs: MicroRNAs Located on Xq27.3 Associate with Clear Cell Renal Cell Carcinoma
Liang Zhou et al.
PLOS ONE (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
Ben Langmead et al.
GENOME BIOLOGY (2009)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis
AJ Czaja et al.
JOURNAL OF HEPATOLOGY (2004)
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
JB Dixon et al.
HEPATOLOGY (2004)
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct
P Hammel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
